Reading view
Dense RNA motif modifications enable robust in vivo prime editing and enhance efficiencies of diverse editing systems
Nature Biomedical Engineering, Published online: 11 September 2026; doi:10.1038/s41551-026-01787-4
Applying extensive chemical modifications to RNA motifs substantially enhances prime editing efficiency in vivo and can be applied for improved efficiencies across RNA-based editing systems.Itaconate and its derivatives in human health and diseases
Signal Transduct Target Ther. 2026 Sep 4;11(1):363. doi: 10.1038/s41392-026-02936-6.
ABSTRACT
Metabolic reprogramming forms the foundation of immune effector functions and the regulation of inflammation. As a pivotal node connecting the tricarboxylic acid cycle to immune signaling, the IRG1/ACOD1 and itaconate axes play a central role in coordinating inflammatory tone and redox balance. Itaconate, generated through the decarboxylation of cis aconitate, acts as an immunometabolic brake that engages multiple regulatory pathways to sustain the dynamic equilibrium between inflammation and tissue homeostasis. Across a broad spectrum of pathological conditions, including infectious diseases, metabolic disorders, ischemia‒reperfusion injury, neurodegenerative diseases, autoimmune disorders, and cancers, itaconate and its derivatives generally exert anti-inflammatory and cytoprotective effects. However, within specific microenvironments, these molecules may also be exploited by pathogens to evade immune clearance or promote immunosuppressive and protumorigenic responses. Future studies should further elucidate tissue- and lineage-specific functions, define bidirectional regulatory mechanisms, and optimize the pharmacokinetic properties of itaconate derivatives. With the advancement of multiomics integration, systems immunology, rational drug design, and engineered itaconate delivery technologies, the IRG1/ACOD1-itaconate axis and derivative-based therapeutic strategies are poised to emerge as key metabolic checkpoints and therapeutic targets in inflammatory-, metabolic-, immune-, and cancer-related diseases.
PMID:42693110 | PMC:PMC13542262 | DOI:10.1038/s41392-026-02936-6
Author Correction: Low-protein diet enhances antitumor immunity in pancreatic cancer through microbiota-derived UDP-galactose
Nature Cancer, Published online: 25 August 2026; doi:10.1038/s43018-026-01241-z
Author Correction: Low-protein diet enhances antitumor immunity in pancreatic cancer through microbiota-derived UDP-galactoseScaleAcross Explorer: Exploring Communication Optimization for Scale-Across AI Model Training
HiGraph: A Large-Scale Hierarchical Graph Dataset for Malware Analysis
XPO1 inhibitor KPT-330 disrupts the core transcriptional regulatory circuitry of dedifferentiated liposarcoma by modulating the translation process
Oncogene, Published online: 16 April 2026; doi:10.1038/s41388-026-03794-w
XPO1 inhibitor KPT-330 disrupts the core transcriptional regulatory circuitry of dedifferentiated liposarcoma by modulating the translation processApplication of machine learning in osteoporosis screening: a narrative review
npj Digital Medicine, Published online: 11 April 2026; doi:10.1038/s41746-026-02516-6
Application of machine learning in osteoporosis screening: a narrative reviewGenetically encoded fluorescent reporters to visualize α-synuclein pathology in live brain
RetroAgent: From Solving to Evolving via Retrospective Dual Intrinsic Feedback
Targeting cell death in Crohn’s disease: from mechanisms to medicines
Cell Death Discovery, Published online: 10 March 2026; doi:10.1038/s41420-026-03005-1
Targeting cell death in Crohn’s disease: from mechanisms to medicines